GLP-1 Ireland Briefing

GLP-1 Reimbursement, Regulation and Safety Updates

Dated, sourced notes for clinicians, pharmacists, policy teams and journalists: NCPE and HSE reimbursement steps, HPRA and EMA decisions, supply and published private prices.

Each note links to the official record it reports. Cite or link it freely; corrections go to our contact page. Looking for plain-English basics instead? Read the GLP-1.ie blog.

Reimbursement

NCPE Wegovy Assessment 25024: What Happens Next at the HSE

For clinicians, pharmacists and journalists: what the NCPE's 13 October 2026 Wegovy recommendation means, the HSE decision path and where Mounjaro stands.

Standing references: HSE reimbursement status by medicine, published Irish pharmacy prices by dose and online-supply safety checks.

Could GLP-1 treatment suit you?

Three questions, about two minutes. See your BMI band against the criteria Irish providers publish.

Check your eligibility